Speciality Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Education Dialogues
    • Business Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Speciality Medical Dialogues
    • Editorial
    • News
        • Anesthesiology
        • Cancer
        • Cardiac Sciences
        • Critical Care
        • Dentistry
        • Dermatology
        • Diabetes and Endo
        • Diagnostics
        • ENT
        • Featured Research
        • Gastroenterology
        • Geriatrics
        • Medicine
        • Nephrology
        • Neurosciences
        • Nursing
        • Obs and Gynae
        • Ophthalmology
        • Orthopaedics
        • Paediatrics
        • Parmedics
        • Pharmacy
        • Psychiatry
        • Pulmonology
        • Radiology
        • Surgery
        • Urology
    • Practice Guidelines
        • Anesthesiology Guidelines
        • Cancer Guidelines
        • Cardiac Sciences Guidelines
        • Critical Care Guidelines
        • Dentistry Guidelines
        • Dermatology Guidelines
        • Diabetes and Endo Guidelines
        • Diagnostics Guidelines
        • ENT Guidelines
        • Featured Practice Guidelines
        • Gastroenterology Guidelines
        • Geriatrics Guidelines
        • Medicine Guidelines
        • Nephrology Guidelines
        • Neurosciences Guidelines
        • Obs and Gynae Guidelines
        • Ophthalmology Guidelines
        • Orthopaedics Guidelines
        • Paediatrics Guidelines
        • Psychiatry Guidelines
        • Pulmonology Guidelines
        • Radiology Guidelines
        • Surgery Guidelines
        • Urology Guidelines
    LoginRegister
    Speciality Medical Dialogues
    LoginRegister
    • Home
    • Editorial
    • News
      • Anesthesiology
      • Cancer
      • Cardiac Sciences
      • Critical Care
      • Dentistry
      • Dermatology
      • Diabetes and Endo
      • Diagnostics
      • ENT
      • Featured Research
      • Gastroenterology
      • Geriatrics
      • Medicine
      • Nephrology
      • Neurosciences
      • Nursing
      • Obs and Gynae
      • Ophthalmology
      • Orthopaedics
      • Paediatrics
      • Parmedics
      • Pharmacy
      • Psychiatry
      • Pulmonology
      • Radiology
      • Surgery
      • Urology
    • Practice Guidelines
      • Anesthesiology Guidelines
      • Cancer Guidelines
      • Cardiac Sciences Guidelines
      • Critical Care Guidelines
      • Dentistry Guidelines
      • Dermatology Guidelines
      • Diabetes and Endo Guidelines
      • Diagnostics Guidelines
      • ENT Guidelines
      • Featured Practice Guidelines
      • Gastroenterology Guidelines
      • Geriatrics Guidelines
      • Medicine Guidelines
      • Nephrology Guidelines
      • Neurosciences Guidelines
      • Obs and Gynae Guidelines
      • Ophthalmology Guidelines
      • Orthopaedics Guidelines
      • Paediatrics Guidelines
      • Psychiatry Guidelines
      • Pulmonology Guidelines
      • Radiology Guidelines
      • Surgery Guidelines
      • Urology Guidelines
    • Home
    • News
    • Diabetes and Endo
    • One-hour Glucose a...

    One-hour Glucose a better predictor of Diabetes risk, finds new study

    Written by Medha Baranwal Baranwal Published On 2019-01-05T20:28:15+05:30  |  Updated On 5 Jan 2019 8:28 PM IST
    One-hour Glucose a better predictor of Diabetes risk, finds new study

    A new study appearing in the Journal of Clinical Endocrinology & Metabolism has found that one-hour glucose level during an oral glucose tolerance test (OGTT) is a strong predictor for future risk of type 2 diabetes (T2D), outperforms the two-hour glucose level and is cheaper to measure than metabolites.


    Early dysglycaemia prediction is crucial for preventing the progression of type 2 diabetes. The one-hour post-load plasma glucose (1-h PG) has been reported as a better dysglycaemia predictor compared with 2-h PG, fasting plasma glucose (FPG), and glycated hemoglobin (HbA1c).


    Gopal Peddinti, VTT Technical Research Center of Finland Ltd, Espoo, Finland, and colleagues conducted this Botnia Prospective Study to evaluate the predictive performance of clinical markers, metabolites, HbA1c, and plasma glucose (PG) and serum insulin (INS) levels during a 75-gram OGTT.


    They evaluated 1,527 predictive models which included various combinations of these variables.


    Also Read: Renal denervation regulates blood glucose levels: JACC study

    Key Findings:

    • Among the plasma glucose measurements, the one-hour plasma glucose showed the best predictive performance for type 2 diabetes, with 75% sensitivity, 68% specificity and 75% accuracy (by AUC), followed by the 30-minute plasma glucose, with 62% sensitivity, 71% specificity and 71% accuracy. Both measures were more accurate than fasting plasma glucose or two-hour plasma glucose.

    • One-hour plasma glucose also outperformed every other metabolite except mannose (which was not significantly worse), and no combination of metabolites significantly outperformed one-hour plasma glucose alone.

    • Several combinations of metabolic markers, clinical risk factors, and one-hour plasma glucose outperformed one-hour plasma glucose alone. But the addition of one-hour plasma glucose improved the predictive performance of 184 models without it, including every combination of metabolites with and without the clinical risk factors.

    • The addition of HbA1c alone did not significantly improve the performance of any of the models.


    Also Read: One egg a day may lower diabetes risk, finds new study

    "Individuals with 1-hour PG >=8.6 mmol/L (155 mg/dl) have a very high risk of developing T2D and should be subjected to adequate life-style intervention and follow-up," Dr. Peddinti told Reuters Health. "Our study, in principle, indicates that metabolite measurements could improve our ability to identify individuals at risk of T2D, but cheaper and more accurate assays to measure metabolites would be needed to realize their added value in practice."





    "Metabolites add to the predictive value of PG and HbA1c measurements. Shortening the standard 75-gram OGTT to one hour improves its predictive value as well as clinical usability," concluded the authors.


    For further reference log on to https://doi.org/10.1210/jc.2018-01828




    blood sugardiabetes riskdysglycaemiaGlycated hemoglobinGopal PeddintiHbA1cJournal of Clinical Endocrinology & MetabolismmannosemetabolitesOGTTone hourone hour plasma glucoseoral glucose tolerance testplasma glucosepredictortesttwo hour plasma glucoseType-2 diabetes
    Source : With inputs from Journal of Clinical Endocrinology & Metabolism

    Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd

    Medha Baranwal Baranwal
    Medha Baranwal Baranwal
      Show Full Article
      Next Story
      Similar Posts
      NO DATA FOUND

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 12 Oct 2022 7:06 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok